NAQUASONE BOLUS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

naquasone bolus

intervet australia pty limited - trichlormethiazide; dexamethasone - oral bolus, chewable - trichlormethiazide ungrouped active 200.0 mg/pb; dexamethasone steroid-glucocorticoid active 5.0 mg/pb - genitourinary system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - oedema | physiological of the mammary g

Coldrex Flu Strength New Zealand - English - Medsafe (Medicines Safety Authority)

coldrex flu strength

glaxosmithkline nz limited - chlorphenamine maleate 2.5mg;  ; dextromethorphan hydrobromide monohydrate 6mg; paracetamol 400mg (300mg fine + 100mg course crystal);  ;  ; pseudoephedrine hydrochloride 30mg - capsule - active: chlorphenamine maleate 2.5mg   dextromethorphan hydrobromide monohydrate 6mg paracetamol 400mg (300mg fine + 100mg course crystal)     pseudoephedrine hydrochloride 30mg excipient: magnesium stearate maize starch purified talc sodium starch glycolate

Intron-A New Zealand - English - Medsafe (Medicines Safety Authority)

intron-a

schering-plough a division of schering-plough animal health limited - interferon alfa-2b 5 miu/ml;   - solution for injection - 5 miu/ml - active: interferon alfa-2b 5 miu/ml   excipient: albumin dibasic sodium phosphate glycine methyl hydroxybenzoate monobasic sodium phosphate monohydrate propyl hydroxybenzoate water for injection

Noxafil New Zealand - English - Medsafe (Medicines Safety Authority)

noxafil

merck sharp & dohme (new zealand) limited - posaconazole 40 mg/ml - oral suspension - 40 mg/ml - active: posaconazole 40 mg/ml excipient: cherry flavour 13174 citric acid monohydrate glucose liquid glycerol polysorbate 80 purified water simeticone sodium benzoate sodium citrate dihydrate titanium dioxide xanthan gum

Polaramine New Zealand - English - Medsafe (Medicines Safety Authority)

polaramine

bayer new zealand limited - dexchlorpheniramine maleate 0.4 mg/ml;   - syrup - 2 mg/5ml - active: dexchlorpheniramine maleate 0.4 mg/ml   excipient: apricot flavour 15502857 blood orange flavour sc481962 ethanol menthol methyl hydroxybenzoate ponceau 4r propyl hydroxybenzoate purified water sodium chloride sodium citrate dihydrate sorbitol sucrose - hayfever and year round allergies: sneezing, watery itchy eyes itchy skin from hives, insect bites.

DiproSalic 0.05% w/w + 2% w/w Scalp Application Ireland - English - HPRA (Health Products Regulatory Authority)

diprosalic 0.05% w/w + 2% w/w scalp application

ltt pharma limited - betamethasone; salicylic acid - cutaneous solution - 0.05 %w/w + 2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone - corticosteroids, potent, other combinations - it is a synthetic fluorinated corticosteroid. in combination with salicylic acid it is indicated for the treatment of chronic lichenified eczema, lichen planus, lichen simplex and non bullous ichthyosiform erythroderma. it is also effective in the less responsive conditions such as psoriasis of the scalp and chronic plaque psoriasis of the hands and feet but excluding widespread plaque psoriasis.

Noxafil New Zealand - English - Medsafe (Medicines Safety Authority)

noxafil

merck sharp & dohme (new zealand) limited - posaconazole 100mg - modified release tablet - 100 mg - active: posaconazole 100mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose hypromellose acetate succinate magnesium stearate microcrystalline cellulose opadry ii yellow 85f92209 - indicated for use in the treatment of the following invasive fungal infections in patients 18 years of age or older: - invasive aspergillosis in patients with disease that is refractory to, or are intolerant of, amphotericin b, itraconazole or voriconazole. - oesophageal candidiasis or candidemia in patients with disease that is refractory to, or who are intolerant of, amphotericin b, fluconazole, or itraconazole. - fusariosis, zygomycosis, cryptococcosis, chromoblastomycosis, and mycetoma in patients with disease refractory to other therapy, or patients who are intolerant of other therapy. - coccidioidomycosis noxafil tablets are also indicated for use as: - prophylaxis of invasive fungal infections, including both yeasts and moulds, in patients 13 years of age and older who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Bonefos 400mg capsule Malta - English - Medicines Authority

bonefos 400mg capsule

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - clodronate disodium - hard capsule - clodronate disodium 400 mg - drugs for treatment of bone diseases

COOPERS OVILIS FOOTVAX SHEEP AND LAMB FOOTROT VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

coopers ovilis footvax sheep and lamb footrot vaccine

intervet australia pty limited - concentrated antigens of dichelobacter nodosus; light liquid paraffin; thiomersal - misc. vaccines or anti sera - concentrated antigens of dichelobacter nodosus vaccine-antigen/antibody active 100.0 ug/ml; light liquid paraffin ungrouped other 600.0 ul/ml; thiomersal mercury other 0.05 mg/ml - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - footrot - dichelobacter nodosus